Turbochargers to boost General Motors’ Chevrolet Corvette ZR1 Featuring 5.5-liter flat plane crankshaft V8 engine Turbochargers utilize patented decoupled ball bearing system, enabling faster response time, higher durability, and limited noise Long-standing reputation with NTT INDYCAR SERIES played role in selection AUBURN HILLS, Mich. , Sept. 23, 2024 /PRNewswire/ — BorgWarner, a global product leader…

Exclusive Development and Commercialization Rights to BA3362 BioAtla An Exciting Partnership It is with great pleasure that we announce the exclusive agreement between BioAtla, Inc. and Context Therapeutics Inc. to develop and commercialize BA3362, a groundbreaking CAB antibody therapeutic for the treatment of solid tumors. This partnership represents a significant step forward in the field…

Welcome to the Circus: The Wild World of Shareholder Rights Litigation Don’t Be a Clown, Know Your Rights! Hey there, fellow investors! Have you heard about the latest class action lawsuit against New Fortress Energy Inc.? If not, no worries, I’m here to break it down for you in a way that’s both informative and…

Welcome to the HPE Magic Quadrant Party! Let’s Celebrate HPE’s 15th Time as a Leader in Primary Storage Platforms Hey there storage geeks, tech enthusiasts, and data lovers! Guess what? Hewlett Packard Enterprise (NYSE: HPE) just scored big in the latest Gartner Magic Quadrant for Primary Storage Platforms. Yep, you read that right – HPE…

Transaction in Own Shares 20 September, 2024 Shell plc Announces Purchase of Shares Shell plc (the ‘Company’) announces that on 20 September 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase 20/09/2024 Number of Shares purchased 898,705 Highest price paid £25.7950 Lowest…

Celebrating a Milestone: Zolbetuximab Approved in the EU for Gastric Cancer Treatment The Breakthrough Therapy Imagine a world where advanced gastric cancer can be treated effectively with a targeted therapy. That world is now a reality with the approval of zolbetuximab in the European Union. This groundbreaking therapy targets claudin 18.2, a biomarker expressed in…

Expanding Domestic Lithium Production: A Milestone for the U.S. Energy Industry The Exciting News from Standard Lithium and Equinor LEWISVILLE, Ark., Sept. 20, 2024 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium”) (TSXV:SLI) (NYSE:A:SLI), a leading near-commercial lithium development and technology company and Equinor, a global energy leader, today announced that its jointly-owned U.S. subsidiary,…